Using algorithms in Developer XD, we developed a protocol for the computer-assisted segmentation of beta cell images and the identification of ISGs (Fig. 2a d).
When McGinn sent a letter asking the pension system governing board to look into divesting fossil fuel stocks from $2.6 billion in retirement funds it controls, he found that Seattle hadn't yet developed a protocol for making such decisions.
To overcome this problem we developed a protocol for whole-mount testis immunostaining yielding high-quality preparations for confocal microscopy.
Recently, our group has developed a protocol for fast estimation of cell count using the Methylene Blue Dye Reduction Test (MBRT) (Bapat et al. [2006]).
In conclusion, we developed a protocol for the modification of proteins with MDA, which not only induces protein polymerization, but also endowed the protein with a fluorescence property.
In particular, starting from the homodimeric DF3 structure, we developed a protocol for covalently linking the two α2 monomers by using the Cu(I) catalyzed azide alkyne cycloaddition.
In order to provide a reliable source of human renal cells, we developed a protocol for the differentiation of human embryonic stem cells into renal epithelial cells.
Here, we have developed a protocol for the efficient generation of a cell-laden and orthogonal-multilayer tissue-engineered (TE) corneal stroma, which is induced by the mechanical effects of compressed collagen (CC) or stretched compressed collagen (SCC).
On the other hand, we have recently developed a protocol for the preparation of a new biodiesel-like biofuel, which integrates glycerol into monoglycerides via 1,3-regiospecific enzymatic transesterification of sunflower oil using free [11] and immobilized [12] [14] porcine pancreatic lipase (PPL).
With help from Applied Biosystems, we have developed a protocol for consistent real-time PCR quantification of transcript abundance from the testes derived from single Drosophila.
We have developed a protocol for purifying pathological PrP aggregates based on immunoprecipitation with a monoclonal antibody that recognizes structural features common to infectious and non-infectious forms of misfolded PrP.
